Parsons Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.83M | Buy |
243,066
+106,825
| +78% | +$2.84M | 0.31% | 71 |
|
|
2025
Q4 | $3.39M | Sell |
136,241
-17,090
| -11% | -$431K | 0.19% | 123 |
|
|
2025
Q3 | $3.91M | Buy |
153,331
+476
| +0.3% | +$11.7K | 0.22% | 105 |
|
|
2025
Q2 | $3.71M | Sell |
152,855
-105,096
| -41% | -$2.45M | 0.23% | 99 |
|
|
2025
Q1 | $6.54M | Sell |
257,951
-36,813
| -12% | -$963K | 0.36% | 61 |
|
|
2024
Q4 | $7.82M | Buy |
294,764
+159,984
| +119% | +$4.34M | 0.42% | 46 |
|
|
2024
Q3 | $3.9M | Sell |
134,780
-8,233
| -6% | -$240K | 0.25% | 86 |
|
|
2024
Q2 | $4M | Sell |
143,013
-14,164
| -9% | -$390K | 0.27% | 81 |
|
|
2024
Q1 | $4.36M | Buy |
157,177
+15,239
| +11% | +$423K | 0.3% | 79 |
|
|
2023
Q4 | $4.09M | Sell |
141,938
-65,028
| -31% | -$1.97M | 0.29% | 80 |
|
|
2023
Q3 | $6.87M | Buy |
206,966
+2,926
| +1% | +$103K | 0.54% | 39 |
|
|
2023
Q2 | $7.48M | Buy |
204,040
+32,230
| +19% | +$1.25M | 0.57% | 35 |
|
|
2023
Q1 | $7.01M | Buy |
171,810
+10,139
| +6% | +$438K | 0.56% | 36 |
|
|
2022
Q4 | $8.28M | Buy |
161,671
+2,113
| +1% | +$101K | 0.69% | 31 |
|
|
2022
Q3 | $6.98M | Buy |
159,558
+27
| +0% | +$1.31K | 0.63% | 31 |
|
|
2022
Q2 | $8.36M | Sell |
159,531
-468
| -0.3% | -$23.8K | 0.75% | 27 |
|
|
2022
Q1 | $8.28M | Sell |
159,999
-5,422
| -3% | -$281K | 0.63% | 31 |
|
|
2021
Q4 | $9.77M | Buy |
165,421
+2,710
| +2% | +$134K | 0.7% | 28 |
|
|
2021
Q3 | $7M | Buy |
162,711
+7,330
| +5% | +$325K | 0.55% | 38 |
|
|
2021
Q2 | $6.08M | Sell |
155,381
-5,151
| -3% | -$200K | 0.47% | 46 |
|
|
2021
Q1 | $5.82M | Sell |
160,532
-713
| -0.4% | -$25.3K | 0.48% | 42 |
|
|
2020
Q4 | $5.93M | Sell |
161,245
-9,062
| -5% | -$332K | 0.51% | 41 |
|
|
2020
Q3 | $5.93M | Buy |
170,307
+4,346
| +3% | +$152K | 0.58% | 37 |
|
|
2020
Q2 | $5.15M | Sell |
165,961
-228
| -0.1% | -$7.75K | 0.55% | 41 |
|
|
2020
Q1 | $5.15M | Sell |
166,189
-3,509
| -2% | -$120K | 0.66% | 36 |
|
|
2019
Q4 | $6.31M | Sell |
169,698
-4,802
| -3% | -$171K | 0.63% | 36 |
|
|
2019
Q3 | $5.95M | Sell |
174,500
-59,758
| -26% | -$2.17M | 0.64% | 33 |
|
|
2019
Q2 | $9.63M | Sell |
234,258
-3,422
| -1% | -$136K | 1.05% | 19 |
|
|
2019
Q1 | $9.58M | Sell |
237,680
-3,797
| -2% | -$152K | 1.05% | 16 |
|
|
2018
Q4 | $10M | Buy |
241,477
+120
| +0% | +$4.98K | 1.23% | 13 |
|
|
2018
Q3 | $10.1M | Sell |
241,357
-1,325
| -0.5% | -$51K | 1.06% | 13 |
|
|
2018
Q2 | $8.35M | Buy |
242,682
+306
| +0.1% | +$10.5K | 0.95% | 17 |
|
|
2018
Q1 | $8.16M | Sell |
242,376
-4,262
| -2% | -$147K | 0.95% | 17 |
|
|
2017
Q4 | $8.48M | Buy |
246,638
+232
| +0.1% | +$7.91K | 0.94% | 17 |
|
|
2017
Q3 | $8.35M | Sell |
246,406
-274
| -0.1% | -$8.81K | 0.98% | 17 |
|
|
2017
Q2 | $7.86M | Sell |
246,680
-1,834
| -0.7% | -$57.8K | 0.96% | 19 |
|
|
2017
Q1 | $8.07M | Sell |
248,514
-2,467
| -1% | -$77.8K | 1.02% | 16 |
|
|
2016
Q4 | $7.73M | Sell |
250,981
-5,393
| -2% | -$165K | 1.03% | 15 |
|
|
2016
Q3 | $8.24M | Sell |
256,374
-1,107
| -0.4% | -$37K | 1.11% | 14 |
|
|
2016
Q2 | $8.6M | Buy |
257,481
+17,930
| +7% | +$572K | 1.17% | 13 |
|
|
2016
Q1 | $6.74M | Buy |
239,551
+49,159
| +26% | +$1.4M | 0.92% | 20 |
|
|
2015
Q4 | $5.83M | Buy |
190,392
+42
| +0% | +$1.32K | 0.82% | 24 |
|
|
2015
Q3 | $5.67M | Buy |
190,350
+2,503
| +1% | +$80.3K | 0.83% | 24 |
|
|
2015
Q2 | $5.98M | Buy |
187,847
+7,259
| +4% | +$237K | 0.79% | 24 |
|
|
2015
Q1 | $5.96M | Buy |
180,588
+17,523
| +11% | +$557K | 0.84% | 22 |
|
|
2014
Q4 | $4.82M | Buy |
163,065
+3,265
| +2% | +$93.6K | 0.64% | 37 |
|
|
2014
Q3 | $4.48M | Sell |
159,800
-6,357
| -4% | -$178K | 0.62% | 39 |
|
|
2014
Q2 | $4.68M | Sell |
166,157
-3,798
| -2% | -$108K | 0.64% | 39 |
|
|
2014
Q1 | $5.18M | Sell |
169,955
-7,398
| -4% | -$221K | 0.74% | 29 |
|
|
2013
Q4 | $5.15M | Buy |
177,353
+1,455
| +0.8% | +$42.3K | 0.77% | 29 |
|
|
2013
Q3 | $4.79M | Buy |
175,898
+1,674
| +1% | +$45.5K | 0.79% | 29 |
|
|
2013
Q2 | $4.63M | Buy |
+174,224
| New | +$4.81M | 0.79% | 29 |
|
Other funds holding PFE
VCM
VPM
Parsons Capital Management's PFE Position: Q1 2026 in Review
Parsons Capital Management increased its Pfizer (PFE) stake by 78% in Q1 2026, buying an estimated $2.84M and bringing the position to 243,066 shares worth $6.83M. The position accounts for 0.31% of the portfolio, ranked #71.
Parsons Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.1M in Q3 2018. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Parsons Capital Management held 243,066 shares of Pfizer worth $6.83M as of Q1 2026.
- Parsons Capital Management bought 106,825 Pfizer shares in Q1 2026, an estimated $2.84M.
- Pfizer made up 0.31% of Parsons Capital Management's portfolio in Q1 2026, its #71 holding.
- Parsons Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Parsons Capital Management's Pfizer position peaked at $10.1M in Q3 2018.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Parsons Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.